nivolumab,regorafenib,trifluridine tipiracil
bms,bayer,Taiho pharma
[]
#gi23 nick pavlakis showed that regorafenib os compared to placebo for pts with advanced, pretreated upper gi cancer what about tas-102? what would you choose as 3rd/4th line tx for a good ps patient w/ met uppergi ca who had prior 5fu, plat, nivo, iri, taxane, ram 
GI Onc at Hopkins, focusing on #PancreaticCancer, #PrecisionMedicine. Striving to improve patient outcomes.
Originator of #TumorBoardTuesday @TumorBoardTues